UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The hidden link between late‐onset seizures and cerebral amyloid angiopathy: A case–control study

Epilepsia open, 2024-10, Vol.9 (5), p.1723-1730

2024

Volltextzugriff (PDF)

Modern neurophysiological techniques indexing normal or abnormal brain aging

Seizure (London, England), 2024-07

2024

Volltextzugriff (PDF)

Effect of mannitol bolus administration on cerebrospinal fluid pressure in patients with idiopathic intracranial hypertension: a pilot study

Journal of neurology, 2022-11, Vol.269 (11), p.6158-6164

2022

Volltextzugriff (PDF)

Long-term clinical, neurophysiological and neuroimaging follow-up of a patient with hemiparkinson-hemiatrophy syndrome

Journal of the neurological sciences, 2021-10, Vol.429, p.119461, Article 119461

2021

Volltextzugriff (PDF)

Mannitol effectiveness in lowering intracranial pressure in idiopathic intracranial hypertension: A case series

Journal of the neurological sciences, 2021-10, Vol.429, p.119257, Article 119257

2021

Volltextzugriff (PDF)

Hemiparkinsonism-hemiatrophy syndrome: a long-term clinical, neurophysiological, and neuroimaging follow-up study

Neurological sciences, 2023-02, Vol.44 (2), p.731-734

2023

Volltextzugriff (PDF)

Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)

Journal of headache and pain, 2021-05, Vol.22 (1), p.35-35, Article 35

2021

Volltextzugriff (PDF)

Humoral and T-cell response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients: Correlations with DMTs and clinical variables

Neurotherapeutics, 2024-03, Vol.21 (2), p.e00307-e00307, Article e00307

2024

Volltextzugriff (PDF)

De novo myoclonic status epilepticus in Alzheimer disease

Seizure (London, England), 2022-04, Vol.97, p.35-36

2022

Volltextzugriff (PDF)

Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic

Journal of neurology, 2023-02, Vol.270 (2), p.595-600

2023

Volltextzugriff (PDF)

Parkinsonism and corticospinal tracts involvement in hepatic encephalopathy

Journal of the neurological sciences, 2021-10, Vol.429, p.118611, Article 118611

2021

Volltextzugriff (PDF)

A case of neuromyelitis optica spectrum disorder (NMOSD) and acute myositis following SARS-CoV-2 infection

Journal of the neurological sciences, 2021-10, Vol.429, p.119862-119862, Article 119862

2021

Volltextzugriff (PDF)

Late-onset fabry disease due to the p.Phe113Leu variant: the first italian cluster of five families

Metabolic brain disease, 2023-08, Vol.38 (6), p.1905-1912

2023

Volltextzugriff (PDF)

Idiopathic Non‐task‐Specific Upper Limb Dystonia, a Neglected Form of Dystonia

Movement disorders, 2020-11, Vol.35 (11), p.2038-2045

2020

Volltextzugriff (PDF)

Myositis associated to COVID-19 mimics an acute exacerbation in myasthenia gravis patient

Journal of the neurological sciences, 2021-10, Vol.429, p.119865-119865, Article 119865

2021

Volltextzugriff (PDF)

End of dose interval (EDI) symptoms in patients undergoing treatment with natalizumab

Journal of the neurological sciences, 2021-10, Vol.429, p.118177-118177, Article 118177

2021

Volltextzugriff (PDF)

Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study

Journal of the neurological sciences, 2023-12, Vol.455, p.122797-122797, Article 122797

2023

Volltextzugriff (PDF)

Myoclonic status epilepticus in patients with juvenile myoclonic epilepsy: Case reports and review of the literature

Epileptic disorders, 2023-06, Vol.25 (3), p.429-433

2023

Volltextzugriff (PDF)

Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis

Neurological sciences, 2020-12, Vol.41 (Suppl 2), p.491-492

2020

Volltextzugriff (PDF)

Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis

Neurological sciences, 2022-09, Vol.43 (9), p.5229-5236

2022

Volltextzugriff (PDF)

Fremanezumab in the prevention of high-frequency episodic and chronic migraine: Friend (fremanezumab in real world study), the first Italian multicenter, prospective real-life study

Journal of the neurological sciences, 2021-10, Vol.429, p.119272, Article 119272

2021

Volltextzugriff (PDF)

Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site, data from the Italian dystonia registry

Journal of the neurological sciences, 2021-10, Vol.429, p.117641, Article 117641

2021

Volltextzugriff (PDF)

1 – 25 von 114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(103)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The hidden link between late‐onset seizures and cerebral amyloid angiopathy: A case–control study

Modern neurophysiological techniques indexing normal or abnormal brain aging

Effect of mannitol bolus administration on cerebrospinal fluid pressure in patients with idiopathic intracranial hypertension: a pilot study

Long-term clinical, neurophysiological and neuroimaging follow-up of a patient with hemiparkinson-hemiatrophy syndrome

Mannitol effectiveness in lowering intracranial pressure in idiopathic intracranial hypertension: A case series

Hemiparkinsonism-hemiatrophy syndrome: a long-term clinical, neurophysiological, and neuroimaging follow-up study

Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)

Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study

Humoral and T-cell response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients: Correlations with DMTs and clinical variables

De novo myoclonic status epilepticus in Alzheimer disease

Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic

Parkinsonism and corticospinal tracts involvement in hepatic encephalopathy

A case of neuromyelitis optica spectrum disorder (NMOSD) and acute myositis following SARS-CoV-2 infection

Late-onset fabry disease due to the p.Phe113Leu variant: the first italian cluster of five families

Idiopathic Non‐task‐Specific Upper Limb Dystonia, a Neglected Form of Dystonia

Myositis associated to COVID-19 mimics an acute exacerbation in myasthenia gravis patient

End of dose interval (EDI) symptoms in patients undergoing treatment with natalizumab

Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study

Myoclonic status epilepticus in patients with juvenile myoclonic epilepsy: Case reports and review of the literature

Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study

Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis

Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis

Fremanezumab in the prevention of high-frequency episodic and chronic migraine: Friend (fremanezumab in real world study), the first Italian multicenter, prospective real-life study

Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site, data from the Italian dystonia registry

Long term (48-weeks) effectiveness, safety and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in real-world: The early 2 study

Suchergebnisse filtern